User profiles for "author:A Spencer"

Andrew Spencer

- Verified email at monash.edu - Cited by 27836

Alexandra Spencer

- Verified email at newcastle.edu.au - Cited by 16306

Andrew Spencer

- Verified email at essex.ac.uk - Cited by 9459

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

…, R Orlowski, H Goldschmidt, A Spencer… - The lancet …, 2016 - thelancet.com
Treatment of multiple myeloma has substantially changed over the past decade with the
introduction of several classes of new effective drugs that have greatly improved the rates …

Therapeutic strategies for enhancing angiogenesis in wound healing

AP Veith, K Henderson, A Spencer, AD Sligar… - Advanced drug delivery …, 2019 - Elsevier
The enhancement of wound healing has been a goal of medical practitioners for thousands
of years. The development of chronic, non-healing wounds is a persistent medical problem …

Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)

…, F Leal Da Costa, O Sezer, A Spencer… - Blood, The Journal …, 2011 - ashpublications.org
Most patients with newly diagnosed multiple myeloma (MM) are aged> 65 years with 30%
aged> 75 years. Many elderly patients are also vulnerable because of comorbidities that …

[HTML][HTML] ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques

N Van Doremalen, T Lambe, A Spencer… - Nature, 2020 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in December
2019 1, 2 and is responsible for the coronavirus disease 2019 (COVID-19) pandemic 3 …

Euclid definition study report

…, A James, M Kemp, J Martignac, A Spencer… - arXiv preprint arXiv …, 2011 - arxiv.org
Euclid is a space-based survey mission from the European Space Agency designed to
understand the origin of the Universe's accelerating expansion. It will use cosmological …

Development and evaluation of the oral health impact profile.

GD Slade, AJ Spencer - Community dental health, 1994 - europepmc.org
The capacity of dental clinicians and researchers to assess oral health and to advocate for
dental care has been hampered by limitations in measurements of the levels of dysfunction …

[HTML][HTML] Revised international staging system for multiple myeloma: a report from International Myeloma Working Group

…, F Gay, M Attal, R Passera, A Spencer… - Journal of clinical …, 2015 - ncbi.nlm.nih.gov
Purpose The clinical outcome of multiple myeloma (MM) is heterogeneous. A simple and
reliable tool is needed to stratify patients with MM. We combined the International Staging …

[HTML][HTML] Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma

M Dimopoulos, A Spencer, M Attal… - … England Journal of …, 2007 - Mass Medical Soc
Background Lenalidomide is a structural analogue of thalidomide with similar but more
potent biologic activity. This phase 3, placebo-controlled trial investigated the efficacy of …

[HTML][HTML] Daratumumab, bortezomib, and dexamethasone for multiple myeloma

…, X Qin, W Deraedt, T Ahmadi, A Spencer… - … England Journal of …, 2016 - Mass Medical Soc
Background Daratumumab, a human IgGκ monoclonal antibody that targets CD38, induces
direct and indirect antimyeloma activity and has shown substantial efficacy as monotherapy …

[HTML][HTML] Elotuzumab therapy for relapsed or refractory multiple myeloma

…, A Belch, D Reece, M Beksac, A Spencer… - … England Journal of …, 2015 - Mass Medical Soc
Background Elotuzumab, an immunostimulatory monoclonal antibody targeting signaling
lymphocytic activation molecule F7 (SLAMF7), showed activity in combination with …